During a follow-up period of 3 years, among a consecutive series of 423 patients who gave informed consent for recatheterization both 1 and 3 years after coronary artery bypass grafting, the incidence of severely symptomatic patients with New York Heart Association class Ill or IV was 19% (79 of 423). The predictive value of approximately 80 clinical, angiographic and perioperative variables was too low to be of clinical value. Adverse clinical outcome was associated with a high closure rate of the grafts. Forty-six percent of the patients could not undergo reoperation because of unsuitable coronary anatomy. With intensive medical therapy half of these patients improved to functional class I or II, while of those patients who were reoperable 32 % improved to class I or II with intensive pharmacologic treatment instead of reoperation. The nonresponders underwent reoperation, which resulted in improvement of symptoms to functional class I or II in most (83 % ). (Am J Cardiol 1985; 55:362-366) In this report we focus on patients who became severely symptomatic after coronary artery bypass grafting (CABG) during 3 years of follow-up. The following questions were posed: What is their incidence? Can an adverse postoperative outcome be predicted from preoperative or perioperative variables? What are the explanatory factors for this adverse outcome? What is the reoperability rate, how were these patients actually managed and what was their clinical outcome?
Methods
From January 1976 to December 1979, a consecutive series of 637 patients underwent CABG at the Thoraxcenter, Rotterdam. All patients had symptoms before operation despite adequate medical treatment. The complaints were stable or unstable angina. Patients with coexisting valvular or con-genital heart disease, those who had undergone left ventricular (LV) aneurysmectomy, surgery for dysrhythmias, and those with a life expectancy of less than 5 years because of other serious disease were excluded. Four hundred twenty-three patients (66%) agreed to undergo recatheterization at 1 and 3 years after operation, irrespective of their postoperative complaints. These patients constitute the study population. Before CABG, 34% of the patients did not agree to undergo 2 postoperative catheterizations. On the basis of clinical data (age, sex, severity of symptoms and previous myocardial infarction [MI] ) and preoperative angiographic data (severity and extent of coronary artery disease (CAD) and LV function), both groups (no informed consent vs informed consent) were comparable.
Of the 423 patients who formed the study population, 3 died during operation. During a follow-up of 3 years, 79 patients have become severely symptomatic and 341 patients have had no or mild symptoms. (Fig. 1) .
Follow-up and management: All patients were seen every 6 months in the outpatient department over the 3-year period. Severe symptoms (persistent or recurrent) were defined as angina pectoris of New York Heart Association (NYHA) functional class III or IV severity. All but 1 of the 79 severely symptomatic patients could be evaluated with angiography. Reoperability was assessed in joint discussion between the cardiac surgeons and cardiologists. After assessment of reoperability, all severely symptomatic patients were initially treated with intense pharmacologic therapy. The patients who had no adequate response to this treatment and those who desired a reoperation (a minority) underwent reoperation. Intensive pharmacologic therapy consisted of nitrates (shortand long-acting) and P-adrenergic agents, inasmuch as calcium antagonists were not available before 1979.
Of the 341 patients with no or mild symptoms despite initial agreement for recatheterization, 276 actually underwent this procedure at 1 year and 158 at 3 years. The patients who did not undergo recatheterization refused upon reconsideration. Clinically available information indicated that the patients who refused recatheterization did not differ from those who consented.
Coronary angiography: Selective coronary angiography was performed in multiple projections including hemiaxial views. The degree of luminal narrowing was coded according to the guidelines of the American Heart Association.1 The degree of luminal narrowing was assessed visually and scored as less than 50%, 50 to 89%, 90 to 99%, and 100%. The bypass grafts were infused selectively with contrast medium to establish patency.
The severity of the underlying CAD before and after CABG was quantified by the coronary score system developed by Leaman and Brower and their co-workers.sJ This coronary score represents the combined effect of the disease in a segment of the coronary artery weighted according to the significance of that vessel. A score of 0 would indicate no obstructive disease, whereas the higher the score, the greater the severity of disease.
In deriving the postoperative coronary score, a vessel segment supplied by a graft was considered to take over the disease factor, if any, of the graft, provided there was no other total occlusion distal to this segment and proximal to the graft anastomose. This postoperative score represents remaining CAD, taking into account disease in the native system as well as closure of grafts.
From this principle, 2 additional postoperative scores could be derived: the coronary score corrected for CABG immediately after surgery and during follow-up, assuming all grafts patent and normal, representing remaining disease in the native coronary system that could not be effectively bypassed, and the coronary score corrected for CABG assuming all grafts closed (or not placed), representing severity of disease in the total native coronary system during follow-up.
Statistical analysis: Univariate statistical analysis was performed using either the chi-square test or Student t test when appropriate using double-sided distributions. Multivariate discriminant function stepdown function analysis was performed with program P7M of the BMDP statistical package.
Results
Characteristics of the population: Of the 423 patients, 93% were men; mean age was 51.6 f 7.1 years. Sixty-eight percent had a previous MI. Sixteen percent of the patients had l-vessel, 27% had 2-vessel, 50% had 3-vessel and 6% left main CAD. Sixty percent of the patients had an ejection fraction greater than 0.50,24% between 0.30 and 0.50, and 2% less than 0.30; the ejection fraction was unknown in 13%. The perioperative mortality was 0.7% (3 of 423 patients). During a follow-up of 3 years the incidence of severely symptomatic patients was 19% (79 of 420 patients) (Fig. 1) .
Predictability of postoperative clinical outcome: The most important pre-and perioperative clinical and angiographic variables are presented in Tables I, II and  III. Multivariate analysis showed that 3 variables had independent predictive value for postoperative severe angina: a low preoperative coronary score, performance of endarterectomy, and absence of previous MI. Together, these 3 variables correctly predicted 60% of the patients with adverse clinical outcome and 62% of the patients with no or mild symptoms.
Explanatory factors for severe symptoms after bypass surgery: The results of pre-, peri-and postoperative angiographic variables are shown in Table IV and Figure 2 . An adverse clinical outcome is associated with a higher corrected coronary score, caused by a lower patency rate. There were no differences in preoperative extent of CAD, the number of nonbypassed stenoses, or progression of disease in the native coronary circulation.
Reoperability, management and clinical outcome: Reoperability was assessed in 70 patients; 46% of them were unable to undergo reoperation for technical reasons. The actual management and resulting clinical outcome are shown in Figure 3 . Intensive pharmacologic treatment was offered to all patients who could not undergo reoperation.
Discussion
Many patients suffer from angina pectoris after CABG. During a follow-up study of 75 unselected patients, Campeau et al4 found a recurrence rate of angina pectoris of 38% at 1 year after operation, 45% at 3 years and 63% at 7 years. In a follow-up study of 748 patients for 5 to 94 months, Cameron et al5 found a recurrence rate of angina of 21% at 1 year to 37% at 6 years. The severity of angina was generally milder than before operation. The European Coronary Surgery StudyG reported a postoperative recurrence rate of angina of 42% at 1 year and 51% at 3 years. In approximately half of.the patients the symptoms were unchanged or even 637 CONSECUTIVE SERIES OF CAB6 (44) 22 (28) 316 (93) 171 (50) 240 (7 1) 298: I;:{ 101 (30) 17 (5) ' 178 (52) 43 (13) 167 (49) 146 (43) 91 (27) p value: univariate analysis, x2 test. BP = blood pressure; CAD = coronary artery disease; CT = cardiothoracic; Ml = myocardial infarction; NS = not significant. worse than before operation. Rahimtoola7 reported that CABG reduced symptoms in 76 to 90% of patients; 33 to 55% became asymptomatic, 5 to 6% showed deterioration of symptoms after surgery, and angina recurred at an annual rate of 2 to 4%.
Laird-Meeter et al8 studied 1,041 patients with a follow-up of 1 to 10 years (mean 3.5). The incidence of postoperative angina pectoris at 1 year was 30%, at 3 years 46% and at 8 years 50%. However, 89% of these symptomatic patients felt themselves improved by surgery. In this study, approximately 40% of the operated patients reported angina pectoris during a follow-up period of 3 years, which is in agreement with the studies cited earlier. Half of these patients had severe angina pectoris. Thus the incidence of severe symptomatic patients with NYHA class III to IV during a 3-year follow-up was 19%; most of the patients had class III symptoms.
Predictability of clinical outcome after bypass surgery: Obviously, patient management could be Explanatory factors for severe symptoms after bypass surgery: Postoperative angina pectoris is often related to incomplete revascularization, early closure of grafts or progression of coronary sclerosis in the native coronary a.rteries.4!g-13 Adverse clinical outcome was associated with a higher attrition rate of grafts, whereas no differences were found in the rate of incomplete revascularization or progession of CAD in the native system of patients with no or mild symptoms compared with those who had severe symptoms. We do not know the reason for this higher graft closure rate in the symptomatic patients; although a low intraoperative graft flow, performance of endarterectomy and perioperative complications are associated with a higher graft attrition rate, I4 these findings do not imply that all these patients became severely symptomatic, as was the endpoint in this study.
Reoperability rate, management and clinical outcome of severely symptomatic patients: The reoperability rate of severely symptomatic patients was about 50%. In the remainder, coronary anatomy was unsuitable for further surgery. With intensive medical treatment, 50% of these patients improved to NYHA class I or II. Most of the reoperable patients were initially offered intense medical treatment before repeat surgery was advised; with such treatment about onethird of the patients improved to class I or II symptoms. The others underwent reoperation, after which 83% improved to class I, II or III. 
